Analyst Ratings for Inhibikase Therapeutics Inc (IKT)
IKT Rating Summary
IKT Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.00 (+219.1%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$6.00 (+219.1%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/4/2026 | Ladenburg Thalmann | Aydin Huseynov | New Coverage | Buy (N/A) |
4.00 (N/A) |
1.91 (1.88) |
-1.57% | Details |
| 1/21/2026 | BofA Securities | Jason Zemansky | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.65 (1.88) |
13.94% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
